A new multi-center U.S. study, recently published in Orthopedic Research and Reviews, confirms that posterior sacroiliac (SI) ...
PainTEQ Announces Successful Completion of First In-Office LinQ Procedure Under New CMS Billing Code
TAMPA, Fla., Jan. 18, 2024 /PRNewswire/ -- PainTEQ, a leading innovator in minimally invasive sacroiliac (SI) joint dysfunction treatments, has achieved a significant milestone with the successful ...
PainTEQ provides a novel therapy for treating sacroiliac (SI) joint dysfunction, a prevalent source of chronic low back pain. How would you describe your company to someone outside of your industry?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback